Monthly Archives: May 2016

Biochemicals, Biomedical Engineering, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotechnology, Gene Therapy, Genetics, Healthcare, Medical Technologies, Pharmaceuticals

GenQual and R-Pharm collaborate to deliver predictive diagnostics for novel anti-IL-6 antibody for autoimmune diseases

Leave a comment

Seattle, WA, San Francisco, CA and Moscow, Russia, 2016-May-25 — /EPR Biotech News/ — R-Pharm and GenQual are pleased to announce a new collaboration focused on the development of novel predictive diagnostic tools in the area of Rheumatoid Arthritis and Autoimmune diseases.

The GenQual proprietary real-time PCR platform, when applied to the genes that are involved in the manifestation of several autoimmune diseases, allows us to detect and assess single nucleotide polymorphisms. Here, allelic determination is used as potential predictor of the treatment response by the novel anti-IL6 antibody, which is currently in development by R-Pharm.

GenQual Founder and CEO Jonathan Mirich said, “This partnership is exciting for GenQual as we advance in our goal to deliver predictive diagnostic tools for the treatment of autoimmune disorders. We are very excited about the possibilities in this space and are thankful to have quality partners in R-Pharm.”

R-Pharm CEO Vasily Ignatiev indicated the importance of the Autoimmune diseases as an area of the development and growth for R-Pharm, as well as the development of novel diagnostic tools aimed to increase the level of predictive response and efficiency of the upcoming treatment paradigm.

About GenQual
GenQual develops proprietary biomarker diagnostics for autoimmune and oncology indications.  Our personalized medicine products are designed to facilitate early disease detection and diagnosis, and to improve treatment approaches at the molecular level.  GenQual is a privately-held corporation based in Seattle, WA area, USA.

About R-Pharm
R-Pharm is a private Russian pharmaceutical company founded in 2001. It employs over 3,500 highly qualified specialists in 60+ branches. R-Pharm operates in Russia and CIS, USA, Germany, Japan, Turkey/MENA.

The company is involved in R&D, manufacturing (finished dosage forms, biotech and chemical APIs), marketing, sales and distribution of innovative pharmaceutical products in hospital/specialty care therapeutic areas.

R-Pharm collaborates with major international pharmaceutical companies and universities in the fields of drug discovery, development, clinical trials, manufacturing and commercialization.  The company operates several  GMP compliant manufacturing sites in Russia and Germany, research, BD/licensing and marketing affiliates in Japan, Germany, Turkey and US.

Marketed portfolio and pipeline features drugs used in oncology, hematology, autoimmune diseases, HIV, HCV, neurology, diabetes, cardiology, as well as antibiotics, contrast media and anesthesia agents.

Contact

R-Pharm
info@rpharm.ru
www.r-pharm.com/en/

 

GenQual

info@genqual.com
206.659.7825
www.genqual.com

 

Via EPR Network
More Biotech press releases

Biochemicals, Biopharmaceutical, Biotech, Biotech Products, Biotech Solutions, Biotechnology, Healthcare

Nu-Tek Bioscience Announces Availability of Pea Peptones

Leave a comment

Allergen free Peptones for the use in probiotic cultures

Minnetonka, MN, 2016-May-10 — /EPR BIOTECH NEWS/ — Nu-Tek’s Pea Peptone is an excellent alternative to Dairy and Soy Peptones for the production of probiotic cultures. Consumers with known food allergies rely on ingredient labeling for guidance. An Allergen Control Plan is a critical component of a food ingredient manufacturer’s safety initiatives. It not only protects the health and confidence of the consumer, but also the reputation and financial success of the company.

An advantage of allergen management strategies include ingredient selection that eliminates allergens without negatively affecting the performance of the product. Formulating growth media using Nu-Tek Pea Peptone provides such an advantage. Nu-Tek Pea Peptone HPP-A is an excellent source of natural nitrogen and necessary growth factors needed for optimum probiotic culture fermentations.

Our Kosher Pea Peptones are obtained through enzymatic hydrolysis of Animal free and Non-GM pea protein. Pea protein hydrolysates do not require special allergen labeling. Independent university trials have shown excellent growth performance results that compare favorably with soy peptones. In addition, peptones have been shown to improve fermentations versus yeast extract “only” growth media. Today at Nu-Tek Bioscience announced immediate availability of Pea Peptones, enabling developers of probiotics to either enhance their current culture growth rate.

Pea Peptones

Pea Peptones Availability
Pea Peptones is an update driven by customer feedback and is part of Nu-Tek Bioscience’ continuing development of new technologies.

Founded in 2008, Nu-Tek Bioscience LLC is the worldwide manufacture and developer of specialty Peptones that have been designed to enhance Cell growth. The company offers a wide range of Peptones and Yeast Extracts.

For more information, press only:
Cyndi Mueller
952-936-3604
cmueller@nu-tekbioscience.com

For more information on Pea Peptones:
www.nu-tekbioscience.com